BIOLOGICAL · Unmapped registry intervention
filgrastim
Find medicine records ·
Find other trials using this name
Clinical trial
S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung Cancer
NCT00004137
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
carboplatin
Normalized identity: carboplatinView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
paclitaxel
Normalized identity: paclitaxelView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
topotecan hydrochloride
Normalized identity: topotecan hydrochlorideView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedS9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Lung Cancerverified · MONDO: lung cancer
Interventions
filgrastimBIOLOGICAL
carboplatinDRUG · verified · RxNorm: carboplatin
paclitaxelDRUG · verified · RxNorm: paclitaxel
topotecan hydrochlorideDRUG · verified · RxNorm: topotecan hydrochloride
Sponsors & collaborators
SWOG Cancer Research Networklead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Los AngelesCalifornia, United States3SeattleWashington, United States3PortlandOregon, United States3DetroitMichigan, United States3New OrleansLouisiana, United States3BostonMassachusetts, United States2San AntonioTexas, United States2CincinnatiOhio, United States2PhoenixArizona, United States2DenverColorado, United States2Oklahoma CityOklahoma, United States2Ann ArborMichigan, United States2
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00004137 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.